Magnetic Diagnostics Potential 42Bio is developing a magnetic separation device and functionalized particles to capture COVID antibodies, signaling opportunities to supply or co develop diagnostic reagents and magnetic device components. Potential partnerships include diagnostic assay developers, serology labs, and veterinary diagnostics teams seeking scalable bead-based platforms.

Strategic Funding Pathways With a small team and modest funding, there are openings for strategic co development, grant funded programs, and milestone based licensing to accelerate scale up of regenerative medicine technologies.

Dual Market Focus The dual focus on human and veterinary health creates channels for partnerships with animal health firms and clinics, enabling licensing or co development of regenerative therapies for both markets.

Regional Collaboration Edge Located in Gainesville, Florida, 42Bio could leverage regional universities and research networks for joint R&D, pilot studies, and access to talent, providing a pathway for sponsored research and early stage validation.

Manufacturing Enablement Partners To move concepts to market, 42Bio may benefit from CRO and CMO collaborations, process development, and regulatory support tailored to magnetic separation devices and biomolecule technologies, including GMP manufacturing and quality systems guidance.